Upon introduction in BRL3A-CD81-CLDN1 or SK-Hep1-CLDN1 cells, eachSR-BI mutant was studied for its capacity to mediate HCV-E2 binding, HCV entryand HDL-induced infection-enhancement. The gene discussed is CLDN1; the disease is infection.